Pulse Brain · Growing Health Evidence Index
Tier 4 — Narrative / commentaryPeer-reviewedSupporting research

Natural compounds proposed for the management of non-alcoholic fatty liver disease

Théodora Merenda, Florian Juszczak, Elisabeth Ferier, Pierre Duez, Stéphanie Patris, Anne‐Émilie Declèves, Amandine Nachtergael

Natural Products and Bioprospecting · 2024

Read source ↗ All evidence

Summary

This narrative review examines the pathophysiology of non-alcoholic fatty liver disease and synthesises evidence for natural compounds as potential therapeutic agents, targeting three key mechanisms: oxidative stress, cellular inflammation, and insulin resistance. The authors conclude that whilst natural compounds show promise in preclinical and some clinical contexts, high-level evidence for efficacy remains limited, and further clinical trials and structured lifestyle intervention research are needed to establish robust, patient-tailored recommendations for NAFLD management.

Regional applicability

The findings are relevant to United Kingdom clinical practice, where NAFLD prevalence is rising and current pharmacological options remain limited. UK practitioners and patients seeking evidence-based natural product interventions would benefit from the mechanistic overview, though the review notes that translation of promising preclinical findings into clinical efficacy requires additional UK and international trials.

Key measures

Oxidative stress markers, inflammatory cytokines, insulin resistance parameters, and hepatic steatosis endpoints in NAFLD models and patients

Outcomes reported

The review synthesised evidence on natural compounds targeting oxidative stress, cellular inflammation, and insulin resistance in NAFLD across in vitro, in vivo, and clinical studies. It assessed the efficacy and mechanisms of action of plant-derived compounds as potential therapeutic interventions for NAFLD management.

Supporting research

Exact full PMC review describes dietary fibre fermentation and bile-acid/lipid metabolism, energy-restricted dietary management and curcumin clinical supplementation studies alongside pharmacological treatments. This is substantive nutritional content within a mixed clinical review.

Limits: Narrative synthesis of heterogeneous clinical/preclinical natural-compound studies; no independent verification of the cited trials, pooled effect or clinical recommendations. Current nomenclature and therapeutic statements require date/context checks before reuse.

Theme
Nutrition & health
Subject
Other / interdisciplinary
Study type
Narrative Review
Study design
Narrative review
Source type
Peer-reviewed study
Status
Published
System type
Human clinical
DOI
10.1007/s13659-024-00445-z
Catalogue ID
SNmup1yh6e-mrfc7v

Topic tags

Pulse AI · ask about this record

Dig deeper with Pulse AI.

Ask about this record, its theme or its relevance to UK farming and policy. Pulse AI uses selected catalogue evidence and cites the sources it draws on.